Recent Finacing
Recent Raise
Pharminox discovers and develops small-molecule cancer therapeutics targeting DNA damage and DNA repair inhibition, advancing lead programme PMX 500 to induce rapid cancer cell death.
Focus Areas
Total Raised
Funding round